Ad
related to: difference between urology and oncology
Search results
Results From The WOW.Com Content Network
The treatment of genitourinary cancer is managed by either a urologist or an oncologist, depending on the treatment type (surgical or medical). Most urologic oncologists in Western countries use minimally invasive techniques (laparoscopy or endourology, robotic-assisted surgery) to manage urologic cancers amenable to surgical management.
Oncology is a branch of medicine that deals with the study, treatment, diagnosis, and prevention of cancer. A medical professional who practices oncology is an oncologist. [1] The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". [2] Oncology is concerned with:
A medical specialty is a branch of medical practice that is focused on a defined group of patients, diseases, skills, or philosophy.Examples include those branches of medicine that deal exclusively with children (), cancer (), laboratory medicine (), or primary care (family medicine).
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. [27] Most prostate cancers are slow growing; however, some grow relatively quickly. [28] [29] The cancer cells may spread from the prostate to other areas of the body, particularly the bones and lymph nodes. [30] It may initially cause no ...
Transitional cell carcinoma is a type of cancer that arises from the transitional epithelium, a tissue lining the inner surface of these hollow organs. [1] It typically occurs in the urothelium of the urinary system; in that case, it is also called urothelial carcinoma.
Bladder cancer is most common in wealthier regions of the world, where exposure to certain carcinogens is highest. It is also common in places where schistosome infection is common, such as North Africa. [56] Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2]
Urology, pathology Papillary urothelial neoplasm of low malignant potential ( PUNLMP ) is an exophytic (outward growing), (microscopically) nipple-shaped (or papillary) pre-malignant growth of the lining of the upper genitourinary tract (the urothelium ), which includes the renal pelvis , ureters , urinary bladder and part of the urethra .
In 2007, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) began using the umbrella term urologic chronic pelvic pain syndromes , for research purposes, to refer to pain syndromes associated with the bladder (i.e. interstitial cystitis/painful bladder syndrome, IC/PBS) and the prostate gland (i.e. chronic prostatitis ...